Dow Up 0.08% Nasdaq Down 0.30%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
9.10 Down 0.99(9.81%) 3:59PM EDT
|After Hours : 9.07 Down 0.03 (0.33%) 7:22PM EDT
Prev Close:10.09
Open:10.09
Bid:9.01 x 100
Ask:9.07 x 400
1y Target Est:29.33
Beta:-0.64
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:9.00 - 10.17
52wk Range:8.88 - 29.79
Volume:2,298,543
Avg Vol (3m):666,350
Market Cap:210.29M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RPRXDown 9.81%210.29M
ABTDown 0.23%65.55B
ACTUp 1.63%63.90B
AUXLUp 0.06%1.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback